Literature DB >> 24675722

Cardioprotective function of cardiac macrophages.

Katsuhito Fujiu1, Jack Wang, Ryozo Nagai.   

Abstract

The heart is composed of several cell types including cardiomyocytes, cardiac fibroblasts, endothelial, and smooth muscle cells. In addition to these major cell types, cardiac macrophages are also present in small numbers under physiological conditions. Recently, the resident macrophage is considered to have vital functions in the maintenance of tissues and homeostasis in many organs, including brain, liver, adipose tissue, lymphatic tissue, and intestinal tract. However, detailed functions of the cardiac resident macrophage are not fully understood. Although the removal of debris arising from damaged cardiomyocytes and pro-inflammatory effects after heart injuries are conventional tasks of cardiac macrophages (classically activated macrophage or M1 macrophage), novel functions like anti-inflammatory roles, adaptive response, and tissue maintenance have also been reported in recent years. Macrophages that possess these novel functions are generally so-called M2 macrophages, which are alternatively activated and show anti-inflammatory phenotype under pathological conditions. In this review, we focus on the cardioprotective function of the cardiac macrophage and discuss in light of unveiled fundamental functions of macrophages that have been also found in other organs.

Keywords:  Alternative activated; Heart; Heart failure; M2; Macrophage

Mesh:

Year:  2014        PMID: 24675722     DOI: 10.1093/cvr/cvu059

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  46 in total

Review 1.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 2.  Macrophage Plasticity and Function in the Eye and Heart.

Authors:  Zelun Wang; Andrew L Koenig; Kory J Lavine; Rajendra S Apte
Journal:  Trends Immunol       Date:  2019-08-15       Impact factor: 16.687

3.  CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.

Authors:  Raffaele Altara; Marco Manca; Marleen H Hessel; Yumei Gu; Laura C van Vark; K Martijn Akkerhuis; Jan A Staessen; Harry A J Struijker-Boudier; George W Booz; W Matthijs Blankesteijn
Journal:  J Cardiovasc Transl Res       Date:  2016-06-06       Impact factor: 4.132

Review 4.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

5.  Isolation and Identification of Extravascular Immune Cells of the Heart.

Authors:  Laura Aronoff; Slava Epelman; Xavier Clemente-Casares
Journal:  J Vis Exp       Date:  2018-08-23       Impact factor: 1.355

6.  PTEN inhibitor VO-OHpic attenuates inflammatory M1 macrophages and cardiac remodeling in doxorubicin-induced cardiomyopathy.

Authors:  Taylor A Johnson; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-10       Impact factor: 4.733

7.  Cortical bone-derived stem cell therapy reduces apoptosis after myocardial infarction.

Authors:  Alexander R H Hobby; Thomas E Sharp; Remus M Berretta; Giulia Borghetti; Eric Feldsott; Sadia Mohsin; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-23       Impact factor: 4.733

8.  Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury.

Authors:  Chunxiao Wang; Congcong Zhang; Luxin Liu; Xi A; Boya Chen; Yulin Li; Jie Du
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

9.  P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9.

Authors:  Kristine Y DeLeon-Pennell; Lisandra E de Castro Brás; Rugmani Padmanabhan Iyer; Dustin R Bratton; Yu-Fang Jin; Crystal M Ripplinger; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2014-09-18       Impact factor: 5.000

Review 10.  Immunomodulation by Exosomes in Myocardial Infarction.

Authors:  Wen Pan; Yujiao Zhu; Xiangmin Meng; Chenlin Zhang; Yan Yang; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2018-10-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.